MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Striatum"

  • MDS Virtual Congress 2020

    Striatal neurodegeneration in the presymptomatic phase of X-linked Dystonia-Parkinsonism

    H. Hanssen, M. Heldmann, J. Dy, J. Tantianpact, J. Steinhardt, A. Sprenger, A. Domingo, C. Reyes, R. Rosales, C. Klein, T. Münte, A. Westenberger, J. Oropilla, C. Diesta, N. Brüggemann (Luebeck, Germany)

    Objective: To identify structural brain changes in patients with X-linked dystonia-parkinsonism (XDP) and non-manifesting carriers of the TAF1 SVA retrotransposon insertion (NMC). Background: XDP is…
  • MDS Virtual Congress 2020

    Perillyl alcohol restores mitochondrial dysfunction and abridge NLRP3 inflammasomes activation in in-vitro and in-vivo model of Parkinson’s disease

    P. Panda, S. Ahmed, V. Naidu (Kamrup, India)

    Objective: Parkinson's disease (PD) affects around 2-3% population of age greater than 65 and is the second most common neurogenerative disorder. The molecular mechanism underpinning…
  • MDS Virtual Congress 2020

    Dopaminergic denervation in de-novo Parkinson’s disease. Does functional somatotopy plays a role?

    J.A Pineda-Pardo, A. Sánchez-Ferro, M. HM Monje, J.A Obeso (Móstoles, Spain)

    Objective: To clarify how dopaminergic denervation occurs along the dorsoventral axis of the posterior putamen in the earliest stages of PD. Background: Dopamine loss in…
  • 2019 International Congress

    7,8- Dihydroxyflavone prevents 3-NitropropionicAcid (3-NP)-induced Striatal Toxicity by Modulating the TrkB receptor and Microglial Activation Pathway

    S. Ahmed, M. Kwatra, VGM. Naidu (Kamrup, India)

    Objective: Hungtion’s disease (HD) is an autosomal governing neurodegenerative disorder caused by production of mutant hungtingtin(Htt) protein followed by death of the GABAergic neurons in…
  • 2019 International Congress

    Quercetin Regulates Cadmium Induced Motor Dysfunction in Depletion of Dopamine and its Metabolites at Synapse

    R. Gupta, RK. Shukla, AB. Pant, VK. Khanna (Lucknow, India)

    Objective: The present study has an attempt to understand cadmium induced alteration in dopamine and associated signaling that causes the motor alterations in rats and…
  • 2019 International Congress

    Toning down SPNs to improve motor responses to dopaminergic stimulation in Parkinson’s disease

    G. Beck, H. Mochizuki, S. Papa (Atlanta, GA, USA)

    Objective: This study was aimed at examining whether decreasing the baseline SPN firing frequency towards the low activity found in normal conditions reduces LID. Background:…
  • 2019 International Congress

    RNA binding protein mediated regulation of striatal transcriptome in Parkinson’s disease.

    K. Irmady, C. Hale, C. Scheckel, J. Fak, R. Darnell (New York, NY, USA)

    Objective: To investigate the role of RNA binding protein Elavl in Parkinson’s disease related adaptive changes in the striatal transcriptome. Background: Elav-like (Elavl or Hu)…
  • 2019 International Congress

    Synchronization Study of Regional Local Field Potential in Rat with Dopamine Receptor Stimulation

    SH. Lin, SY. Chen, YY. Chen (Hualien, Taiwan)

    Objective: The aim of this study attempts to explore the non-linear interaction with cross-frequency coupling in rats during the stimulation of dopamine receptors. Background: Investigating…
  • 2019 International Congress

    Change of extracellular glutamate and GABA level in striatum during deep brain stimulation of the entopeduncular nucleus in rats

    CB. Cho, JH. Sung (Suwon, Republic of Korea)

    Objective: Globus pallidus interna (GPi) is recognized as an effective treatment for advanced Parkinson’s disease. However, the neurochemical basis of its effects remains unknown. The…
  • 2019 International Congress

    Phosphodiesterase 10A and cognition in Parkinson’s disease

    Z. Chappell, G. Pagano, H. Wilson, F. Niccolini, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)

    Objective: We aimed to assess the associations between Phosphodiesterase 10A (PDE10A) expression in the executive striatum and cognitive performance in vivo, using [11C]IMA107 PET and…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley